home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

474.06 -10.08 (-2.08%)

Streaming Delayed Price Updated: 1:28 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

69 70 Next >

Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics ↗

August 29, 2024

Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC.

Via Benzinga

Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗

August 27, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗

August 23, 2024

Via Benzinga

Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead ↗

August 23, 2024

Vertex Pharmaceuticals has a lot going for it.

Via The Motley Fool

Vertex to Participate in Upcoming September Investor Conferences

August 22, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today ↗

August 21, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗

August 09, 2024

Via Benzinga

Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook ↗

August 01, 2024

The company's sales came in a hair light with losses wider than expected.

Via Investor's Business Daily

Biotech Bull Market: 3 Ways To Play It ↗

August 20, 2024

Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.

Via Talk Markets

Topics Economy

Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings ↗

August 19, 2024

Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities...

Via Benzinga

These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond ↗

August 18, 2024

It's always a good time to invest cash in quality businesses.

Via The Motley Fool

3 Fantastic Growth Stocks to Buy in August ↗

August 17, 2024

These stocks should keep up their winning ways.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 15, 2024

Via Benzinga

3 Biotech Stocks to Buy on the Dip: August 2024 ↗

August 15, 2024

These are three of the best biotech stocks to buy on the dip due to their strong fundamentals and market positioning.

Via InvestorPlace

Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them ↗

August 15, 2024

These technologies could be game-changers. And they could make forward-thinking investors a lot of money.

Via The Motley Fool

2 Biotech Stocks to Buy Hand Over Fist in August ↗

August 12, 2024

Both of these biotechs are highly innovative companies.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy in August 2024 ↗

August 08, 2024

These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.

Via InvestorPlace

Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England

August 07, 2024

From Vertex Pharmaceuticals

Via Business Wire

Is It Too Late to Buy Vertex Pharmaceuticals Stock? ↗

August 06, 2024

Shares of the rare disease drugmaker are already up more than 40% over the past year.

Via The Motley Fool

Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 ↗

August 05, 2024

Great companies are found in every type of market landscape.

Via The Motley Fool

3 Biotech Stocks on Track for 50% Returns (or More) by 2028 ↗

August 04, 2024

Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!

Via InvestorPlace

Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker ↗

August 04, 2024

The biotech recently became a commercial-stage company.

Via The Motley Fool

3 Unstoppable Stocks to Buy in August ↗

August 03, 2024

It's not hard to envision how all three of these stocks can deliver exceptional growth.

Via The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now ↗

August 03, 2024

These two healthcare companies have far more upside potential than Johnson & Johnson.

Via The Motley Fool

3 Biotech Stocks That Could Have Investors Grinning Soon ↗

August 02, 2024

Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.

Via InvestorPlace

Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday? ↗

August 02, 2024

Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New York, as a cooler-than-expected July jobs report rattled risk sentiment and...

Via Benzinga

Topics Economy

Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline ↗

August 02, 2024

Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing the $4.14 consensus. The analyst expects strong growth in the pain...

Via Benzinga

Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second. ↗

August 02, 2024

Vertex's first loss in years is a big nothingburger.

Via The Motley Fool

Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript ↗

August 01, 2024

VRTX earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Vertex Reports Second Quarter 2024 Financial Results

August 01, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com